Pitcairn CO Regeneron Pharmaceuticals, Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pitcairn CO holds 962 shares of REGN stock, worth $687,320. This represents 0.06% of its overall portfolio holdings.

Number of Shares

962

Previous 918 4.79%

Holding current value

$687,320

Previous $964,000 4.88%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $45,059 - $52,877	44 Added 4.79%	962 $1.01 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $70,656 - $85,695	80 Added 9.55%	918 $964,000
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $46,037 - $50,660	51 Added 6.48%	838 $806,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $3,875 - $4,408	-5 Reduced 0.63%	787 $691,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $44,316 - $54,039	64 Added 8.79%	792 $651,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $9,100 - $10,794	-13 Reduced 1.75%	728 $523,000
Q1 2023 May 05, 2023	BUY	$680.49 - $826.97 $14,970 - $18,193	22 Added 3.06%	741 $608,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $21,176 - $22,991	30 Added 4.35%	719 $518,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $17,793 - $22,453	31 Added 4.71%	689 $475,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $16,998 - $22,904	31 Added 4.94%	658 $389,000
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $8,926 - $10,476	15 Added 2.45%	627 $438,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1,630 - $2,012	-3 Reduced 0.49%	612 $386,000
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $5,740 - $6,809	-10 Reduced 1.6%	615 $373,000
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $2,836 - $3,351	6 Added 0.97%	625 $349,000
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $6,254 - $7,674	14 Added 2.31%	619 $293,000
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $4,783 - $6,079	-10 Reduced 1.63%	605 $292,000
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $31,050 - $37,517	-57 Reduced 8.48%	615 $344,000
Q2 2020 Jul 28, 2020	BUY	$493.32 - $643.92 $15,292 - $19,961	31 Added 4.84%	672 $419,000
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $21,851 - $32,137	-65 Reduced 9.21%	641 $313,000
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $193,535 - $265,816	706 New	706 $265,000
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $238,730 - $277,954	-873 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $227,696 - $315,263	-760 Reduced 46.54%	873 $274,000
Q1 2019 May 07, 2019	BUY	$372.08 - $439.57 $44,649 - $52,748	120 Added 7.93%	1,633 $670,000
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $671 - $806	2 Added 0.13%	1,513 $565,000
Q3 2018 Nov 02, 2018	SELL	$351.14 - $408.51 $25,984 - $30,229	-74 Reduced 4.67%	1,511 $610,000
Q2 2018 Aug 02, 2018	SELL	$284.6 - $344.99 $11,384 - $13,799	-40 Reduced 2.46%	1,585 $546,000
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $37,582 - $46,859	-119 Reduced 6.82%	1,625 $559,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $24,028 - $31,486	-67 Reduced 3.7%	1,744 $655,000
Q3 2017 Nov 03, 2017	BUY	$431.38 - $504.0 $781,229 - $912,744	1,811	1,811 $810,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account